US Patent:
20120149749, Jun 14, 2012
Inventors:
Michael Arning - Collegville PA, US
Roya Behbahani - Philadelphia PA, US
Yanli Deng - Kingo of Prussia PA, US
Sophia M. Goodison - Collegeville PA, US
Julian Jenkins - King of Prussia PA, US
Shivakumar G. Kapsi - King of Prussia PA, US
Bhabita Mayer - Uxbridge, GB
Francis Xavier Muller - King of Prussia PA, US
Bin Peng - Collegeville PA, US
Teresa S. Sellers - King of Prussia PA, US
Nicole Lee Stone - Collegeville PA, US
Dickens Theodore - Research Triangle Park NC, US
Dennis R. Williams - Collegeville PA, US
Mary Beth Wire - Research Triangle Park NC, US
International Classification:
A61K 31/4152
A61P 7/02
Abstract:
Invented is a method of treating thrombocytopenia in a human in need thereof which comprises the administration of a therapeutically effective amount of a 3′-{N′-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2′-hydroxybiphenyl-3-carboxylic acid to such human.